Development of Neutralization Assay using Murine Leukemia Virus (MuLV) Pseudotyped with Japanese encephalitis Virus (JEV) env Gene

The envelope (E) glycoprotein of JEV is the major antigen to elicit neutralizing antibody (NAb) against JEV infection.In order to develop a rapid and safe neutralization assay system for evaluation of the JEV vaccine strains, we constructed JEV-pseudotyped viruses with JEV env genes (Nakayama-NIH, Beijing-1).The titers of JEV-pseudotyped viruses with NK and BJ strains were 4.0×10 4 IFU/ml and 1.3×10 5 IFU/ml in Vero cell cultures, respectively.We have analyzed the neutralization activity of immunized mouse sera with JEV-NK and JEV-BJ pseudotyped viruses.The neutralizing antibody titers of NK and BJ (50% reduction of virus) were about 1:10,000 at each immunized sera.Compared with conventional plaque reduction neutralization test (PRNT), the method using JEV-pseudotyped virus has desirable advantages such as more rapid, easier, and non-biohazardous.This neutralization assay system might be useful to evaluate NAb activity against JEV vaccine strains or vaccine candidates.